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Structural basis for substrate specificity and
catalysis of α1,6-fucosyltransferase
Ana García-García1,9, Laura Ceballos-Laita 1,9, Sonia Serna2,3, Raik Artschwager2,3, Niels C. Reichardt2,3,4,
Francisco Corzana 5 & Ramon Hurtado-Guerrero 1,6,7,8✉
Core-fucosylation is an essential biological modification by which a fucose is transferred from
GDP-β-L-fucose to the innermost N-acetylglucosamine residue of N-linked glycans. A single
human enzyme α1,6-fucosyltransferase (FUT8) is the only enzyme responsible for this
modification via the addition of an α-1,6-linked fucose to N-glycans. To date, the details of
substrate recognition and catalysis by FUT8 remain unknown. Here, we report the crystal
structure of FUT8 complexed with GDP and a biantennary complex N-glycan (G0), which
provides insight into both substrate recognition and catalysis. FUT8 follows an SN2
mechanism and deploys a series of loops and an α-helix which all contribute in forming the
binding site. An exosite, formed by one of these loops and an SH3 domain, is responsible for
the recognition of branched sugars, making contacts specifically to the α1,3 arm GlcNAc, a
feature required for catalysis. This information serves as a framework for inhibitor design, and
helps to assess its potential as a therapeutic target.
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Core-fucosylation is an essential biological modification ofthe N-glycan core in eukaryotes (except for plants andfungi) that is performed by the inverting α1,6-fucosyl-
transferase (FUT8)1. It is the most common type of fucose
modification and occurs in the Golgi apparatus. FUT8 transfers a
n L-fucose residue from GDP-β-L-fucose (GDP-Fuc) onto the
innermost GlcNAc of N-glycan to form an α1,6-linkage2. Gene
knockout of FUT8 in mice led to early postnatal death, severe
growth retardation and emphysema-like changes in the lung, and
revealed that this modification is crucial for the activation of
growth factor receptors1,3. FUT8 is also involved in cell adhesion
and cell migration processes by influencing turnover and
expression levels of E-cadherin4 and the activity of α3/β1 integ-
rin5. Core-fucose also effects N-glycan conformation by favoring
an extended orientation of the α1,6 arm6. This can lead to subtle
changes in glycan recognition by lectin receptors7. However,
core-fucosylation is likely most known for its capacity to adjust
the humoral immune response by altering antibody-dependent
cellular cytotoxicity (ADCC). Thus, different strategies for redu-
cing core-fucosylation in therapeutic monoclonal antibodies have
been developed to enhance ADCC8. Notably, FUT8 is up-
regulated in numerous types of cancer, suggesting that blocking
its activity could be a promising strategy for improving anti-
tumor immune responses9.
The acceptor specificity of FUT8 requires the presence of a
terminal GlcNAc moiety on the α1,3 arm of the N-glycan but
shows a higher degree of flexibility on the α1,6 arm10. This sub-
strate preference does not necessarily demand the presence of a
peptide/protein10. On the contrary, FUT8 also fucosylates high
mannose N-glycans lacking a terminal GlcNAc moiety on the α1,3
arm. However, in these cases a peptide/protein moiety attached to
the first GlcNAc via an N-glycosidic linkage11 is necessary.
The crystal structure of the human FUT8 (HsFUT8) apo form
has been previously reported revealing that FUT8 is composed of
a multi-domain enzyme that contains an N-terminal coiled-coil
domain, a catalytic domain, which adopts a GT-B fold, and a C-
terminal SH3 domain12. However, the lack of solved ternary
complexes has impeded to obtain mechanistic insights into the
glycosyl transfer reaction or reveal the molecular basis of the
requirement for a terminal GlcNAc moiety on the α1,3 arm for
optimal catalysis. Here, we have captured a ternary complex
formed between the human FUT8 (HsFUT8), GDP and the
biantennary complex N-glycan G0 (see below) by X-ray crystal-
lography, uncovering the molecular basis of FUT8 catalysis and
recognition of acceptor substrates.
Results
Core-fucosylation of synthetic N-glycans by HsFUT8. HsFUT8
was successfully cloned, expressed and purified to homogeneity
(Methods) to enable functional and structural characterization.
The activity of HsFUT8 on 5-aminopentyl G0 was monitored by
mass spectrometry that showed a mass increase of 146 Da corre-
sponding to the incorporation of a fucose moiety into the glycan
in the presence of GDP-Fuc (Supplementary Fig. 1). Then, we
evaluated the HsFUT8 acceptor substrate specificity on a micro-
array of synthetic N-glycans by expanding an earlier array version
used by us in the study of C. elegans FUT8 (CeFUT8)13,14 (Fig. 1,
Supplementary Table 1). The HsFUT8 showed identical substrate
acceptor preferences to the reported ones for CeFUT8 (Fig. 2), and
verified prior reports describing the importance of a terminal
GlcNAc moiety in the α1,3 arm as a requirement for catalysis and
a great promiscuity towards modifications on the α1,6 arm10.
Architecture of the HsFUT8-GDP-G0 complex. Further, we
successfully obtained C2 crystals of HsFUT8 in a complex with
GDP and G0 glycan (Table 1). The resulting crystals allowed us to
solve the structure at high resolution (1.95 Å) and interpret the
density map (Table 1). The asymmetric unit (AU) of C2 crystals
contains two molecules of HsFUT8 that are arranged as dimers
with two molecules from the neighboring AU by direct contact
between their corresponding N-terminal coiled-coil domains
(Fig. 3). The root mean square deviation (RMSD) between both
molecules belonging to chain A and B in the AU is 0.44 Å on 452
equivalent Cα atoms (Fig. 4; hereafter we will only discuss
molecule A because it does not contain any disordered regions).
As expected, the analysis of the HsFUT8 structure with the DALI
server15 revealed structural homology to two fucosyltransferases,
namely the Arabidopsis thaliana FUT1 (AtFUT1; PDB entries
5KX6, 5KOP, 5KOR, 5KWK and 5KOE16,17) and the human and
C. elegans PoFUT2 (HsPoFUT2 and CePoFUT2; PDB entries
4AP5, 4AP6 and 5FOE18–20). Although FUT8 is very distant to
AtFUT1 and HsPoFUT2/CePoFUT2 in terms of acceptor sub-
strates, the server rendered good scores implying that they
superimposed fairly well (RMSDs of ~3.2 and ~5.0 Å between
AtFUT1 and HsFUT8, and AtFUT1 and HsPoFUT2/CePoFUT2
crystal structures, respectively; the superimposed residues ranged
from 429 to 459 residues).
The structure of HsFUT8 complexed to GDP and G0 depicts
the three aforementioned domains and how they are connected
with each other. While the catalytic domain is connected to the
coiled-coil domain by α3, the SH3 domain is connected to the
catalytic domain by the loop β10–β11 (Fig. 4a, Supplementary
Fig. 2). While in general, densities for GDP and the rest of the G0
molecule are very well defined, we only observe partial density for
the GlcNAc moiety on the α1,6 arm (GG0). Of special note is the
anti-ψ conformation for the core-chitobiose GlcNAc moieties
(glycosidic linkage involving units AG0–BG0) of the N-glycan in
the bound state (see below). This conformer is less stable relative
to the typical syn-ψ conformation found in solution21 (see inset in
Fig. 4a). In addition, the Manα1-6Man linkage of G0 adopts an
‘extended gg’ conformer22, with ψ and ω values of 174.7° and
50.4°, respectively. The structure also reveals that GDP is partly
buried and located exclusively in the catalytic domain, while the
inner part and the α1,3/α1,6 arms of G0 are located in the
catalytic domain and the exosite formed by the loop β10–β11 and
SH3 domain, respectively (Fig. 4b). The presence of exosites for
intimate binding to N-glycans was also observed in distant
glycosyltransferases (GTs) and glycosyl hydrolases such as
MGAT2 and MAN2A1, respectively23. Our structure also exhibits
two striking conformational changes relative to the apo form
(RMSD of 0.56 Å on 436 equivalent Cαs; Fig. 4c). Residues
428–444 (formed by a loop and α10) experience a large
conformational change (the largest distance, close to 22 Å, was
observed for Gly437 in both forms) that allows the partial closure
of the GDP-Fuc-binding site and which protects the more
hydrophobic part of the molecule (the guanosine moiety) from
the solvent. Significantly, during the transition from the apo to
the substrate-bound forms, a rearrangement of the α10 takes
place in which α10apo-form (residue 436–442) becomes unstruc-
tured and another α10, comprising residues 430–435, is formed.
Furthermore, the loop β6–α8 (residues 365–378) is partly
disordered in the apo form and suffers a conformational change
in the presence of both ligands, leading to an ordered loop that
contributes to the formation of both the GDP-Fuc and the
acceptor binding sites (Fig. 4c).
The sugar nucleotide-binding site. The HsFUT8-binding site is
large and set up by the GDP-Fuc and the N-glycan binding sites
(Fig. 5a, b). The guanine moiety of GDP establishes CH–π
interactions with Ala436, Val450 and Val471 while the guanosine
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moiety is tethered via hydrogen bonds to Tyr250/His363/
Asp453 side chains and Tyr220/Thr408 backbones. The pyr-
ophosphate interacts with Gly221/Cys222/Gln470 backbones,
Lys369/Arg365/Ser469 side chains and a glycerol moiety. The
presence of positively charged residues like Arg365 and Lys369 is
typically found in GT-B fold GTs, which do not bind to metal
ions24. These residues replace the metal present in GT-A fold GTs
and stabilize the pyrophosphate groups and the right conforma-
tions of sugar nucleotides for catalysis24. The glycerol moiety is a
fucose mimic that occupies a similar position as found for fucose
(see Methods, Fig. 5b, c, Supplementary Fig. 3), and further
interacts with Arg365 and Glu373 side chains, and AG0 OH6, the
site of fucosylation in G0 (Fig. 5b). The GDP-Fuc coordinates
were obtained from the crystal structure of CePoFUT1 complexed
to GDP-Fuc (PDB entry: 3ZY6 (ref. 25)) and the resulting
HsFUT8-GDP-Fuc-G0 complex was further minimized using
molecular mechanics (MM) calculations, as shown in Methods.
Two hydroxyl groups of the glycerol molecule occupy positions
that mimic fucose OH4 and the endocyclic oxygen. In addition,
one of these two hydroxyl groups is also found in interaction
distance of Arg365 and mimics the conserved interaction
observed by the fucose endocyclic oxygen and Arg365 (Fig. 5b, c,
Supplementary Fig. 3). Glu373 side chain further interacts with
AG0 OH6 and Lys369 side chain, which helps stabilize the
negative charge of Glu373 carboxylate. This could improve the
catalytic base character of Glu373 for deprotonating the AG0 OH6
(Fig. 5a, b). The importance of Arg365, Lys369 and Glu373 for
catalysis was previously confirmed by Ala substitutions by site-
directed mutagenesis of these residues, which rendered the
resulting mutants fully inactive12. The location of Arg365, Lys369
and Glu373 in the mobile loop β6–α8 demonstrates the pivotal
relevance of this loop in binding to the ligands and catalysis.
Markedly, structure of HsFUT8 with GDP-Fuc (see Methods) and
G0 could demonstrate the inversion at the anomeric carbon of
fucose with respect to GDP-Fuc (Fig. 5c). Therefore, these results
are compatible with an SN2 single-displacement reaction
mechanism, which is deployed by most inverting GTs24.
The N-glycan-binding site. Unlike the intimate recognition of
GDP by HsFUT8, G0 displays less contacts with the protein
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Fig. 1 Glycan microarray employed for assessing HsFUT8 substrate selectivity. a Pictogram representation of N-glycan structures included on the glycan
array. b Specification of glycosidic bond configurations. c Monosaccharide symbol nomenclature according to Consortium of Functional Glycomics
recommendations. See the following link for further information, http://www.functionalglycomics.org/static/consortium/Nomenclature.shtml.
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(Fig. 5a), in line with previous SPR data in which the binding of
GDP-Fuc was ~40-fold stronger than the binding of G0 to the
enzyme26 (Fig. 5a). AG0 is recognized through hydrogen bonds
formed between AG0 OH1 and Gly217 backbone, AG0 acetamide
NH and Asp295 side chain, and AG0 OH3 and Asp295/Lys216 side
chains. BG0 is tethered via interactions formed between BG0 OH6
and Glu373 side chain, and BG0 acetamide carbonyl group and
Gln470 side chain. The unusual anti-ψ conformation of AG0 and
BG0, which is imposed by the enzyme, is a strict requirement for
the AG0 OH6 fucosylation site facing GDP-Fuc (Fig. 5a). Catalysis
can only take place in the anti-ψ conformation even though this
conformation is less energetically favorable than the solution-phase
syn-ψ conformation (−8.9 versus −9.5 kcal/mol, estimated by MM
calculations for the disaccharide containing AG0–BG0 units).
The sugars forming the branching part of G0 (CG0, DG0, EG0,
FG0 and GG0) are located in the exosite formed by the loop β10–
β11 and the SH3 domain (Fig. 5a). CG0 establishes a CH–π
interaction with Tyr498 and provides one hydrogen bond
between CG0 OH4 and Asp495 side chain. DG0 is poorly
recognized by a lonely hydrogen bond between DG0 OH6 and the
Glu373 backbone. However, the terminal GlcNAc moiety in the
α1,3 arm, EG0, is the most intimately recognized monosaccharide
residue of all branched sugars. EG0 established three hydrogen
bonds that are formed between EG0 OH6 and His535 side chain,
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Fig. 2 Activity assay of HsFUT8 on glycan microarray. a Aleuria aurantia lectin (AAL-555) binding before and after incubation with recombinant HsFUT8
at two different concentrations (650 nM and 3.5 μM) on a selection of glycan structures. b AAL-555-binding profile on a full glycan array before treatment
with recombinant HsFUT8. c AAL-555-binding assay after treatment with recombinant HsFUT8 at 650 nM enzyme concentration and d AAL-555-binding
assay after treatment with recombinant HsFUT8 at 3.25 μM enzyme concentration. Histogram bars show the average fluorescence RFU (relative
fluorescence units) values for four replicate spots on the array. Error bars represent the standard deviation of the average RFU values on the same
microarray. N-glycans that show binding towards AAL after incubation with HsFUT8 are highlighted in blue.
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EG0 OH2 and Asp494 backbone, and EG0 acetamide NH and
Asp495 side chain. In addition, the EG0 acetamide methyl group
is engaged in a hydrophobic interaction with Ala374 (Fig. 5a).
The contacts that EG0 establishes with the enzyme could explain
the strict requirement for a GlcNAc moiety in this position. This
unit improves the binding of the α1,3 arm, and in turn, provides
stabilization of the entire molecule in the bound state. On the
contrary, the branching sugars on the α1,6 arm are far less well
recognized, which provides a plausible explanation for the larger
promiscuity towards the α1,6-mannose branch10. The FG0
endocyclic oxygen and FG0 OH4 establish two hydrogen bonds
with Gln502 side chain and Val531 backbone, respectively, while
other potential interactions between GG0 and HsFUT8 (GG0
carbonyl group and GG0 OH3 with Gly501 and Gln502
backbones, respectively) cannot be confirmed due to the less
well-defined density in this sugar residue (Figs. 4a and 5a). The
addition of a bisecting GlcNAc in G0 would preclude fucosylation
by FUT8 because this residue is likely to impose a significant
steric hindrance to the complex (Fig. 6), explaining why N-
glycans with bisecting GlcNAc are not substrates of FUT8
(ref. 27).
Discussion
FUT8 is the only enzyme responsible for core-fucosylation on
mammalian N-glycoproteins. Despite many years of research on
the enzymology and chemistry of FUT8, its reaction mechanism
remained elusive and the requirement for a terminal GlcNAc
moiety on the α1,3 arm of the N-glycan for optimal fucosylation
was not well understood. The structure of the HsFUT8 apo form
provided the architecture of this enzyme, which is formed by
three different domains12. However, this structure did not offer
any clues for the reaction mechanism or substrate recognition.
Here, we have determined the crystal structure of a functional
HsFUT8 in complex with GDP and G0. Intriguingly, the structure
reveals that residues 436–442, in which one loop and α10 are
present, and the loop β6–α8 suffer large conformational changes
in the presence of the ligands forming the GDP-Fuc and acceptor
binding sites. Though conformational changes of loops have been
visualized in inverting and retaining GTs24,28,29, the motion here
of the loop β6–α8 in the presence of ligands is unique because this
loop brings in key residues that recognize both GDP and G0. In
particular, Arg365, Lys369 and Glu373 contribute not only to the
binding but also to catalysis, with Glu373 acting as the catalytic
base for AG0 OH6. This is compatible with an SN2 single-
displacement reaction mechanism. Generally, GT-A or GT-B
inverting GTs following an SN2 inverting mechanism contain an
amino acid acting as a catalytic base24 (typically Glu, Asp, or His).
However, in most structures, these residues acting as catalytic
residues are already located in the binding site in the absence of
ligands24. Hence and to our knowledge, FUT8 exemplifies a
unique case in which the catalytic base is brought to the binding
site in the presence of ligands (note that the distance of Glu373
Cαs of the apo and substrate-bound form is ca. 18 Å; Fig. 7).
Previously and based on computational studies, HsFUT8 was
suggested to follow an SN2 mechanism in which the β-phosphate
was acting as the catalytic base26. Similarly, the β-phosphate
acting as the catalytic base was proposed for the inverting
CePoFUT125, though in this case an SN1 mechanism was sug-
gested. In both enzymes, there was no basic residue present in the
active site that could act as an assisting base. However, and based
on our crystal structure, it is now clear that the authors could not
predict the motion of the loop β6–α8, which brings the essential
catalytic base Glu373. This demonstrates that it is imperative to
obtain ternary complexes for these enzymes to elucidate their
catalytic mechanism. Our SN2 inverting mechanism is also rein-
forced by the previous elucidation of ternary complexes for the
closest structural homologs, AtFUT1 (ref. 17) and CePoFUT2
(ref. 18). For both enzymes, residues such as Asp and Glu,
respectively, were also acting as the catalytic bases.
At the level of the N-glycan-binding site, four major structural
features are responsible of the selectivity and recognition of
HsFUT8 on N-glycans: (a) the less stable anti-ψ conformation for
the core-chitobiose GlcNAc moieties of the N-glycan in the
bound state is a pre-requisite for core-fucosylation, since it pro-
vides the AG0 OH6 in close contact to GDP-Fuc; (b) the CH–π
interaction between Tyr498 and CG0 is likely crucial for a right
orientation of the branching sugars; (c) the existence of an exosite
formed by the loop β10–β11 and SH3 domain is responsible for
branching sugar recognition and, in particular, for the α1,3 arm
GlcNAc binding. SH3 domains are small protein domains of
about 60 amino acid residues present in a large number of pro-
teins and well-known for driving protein–protein interactions30.
The fact that residues from the HsFUT8 SH3 domain recognize
sugar moieties implies the broad versatility of these domains in
recognition of different molecules; and (d) the most intimately
recognition for the α1,3 arm GlcNAc explains why FUT8 requires
the presence of a terminal GlcNAc moiety on the α1,3 arm of the
N-glycan for optimal fucosylation. This ligand-binding model
also explains our own data using HsFUT8 on a microarray of
synthetic N-glycans and prior reports10,13,14. However, our
structure does not offer clues on how FUT8 fucosylates less
optimally high mannose N-glycans linked to glycoproteins and
peptides that lack a terminal GlcNAc on the α1,3-branch and
which will require further structural studies.
In conclusion, the structure reported here shows how FUT8
recognizes N-glycans and provides information on the enzymatic
mechanism. Our structure may assist in the development of
inhibitors with a potential value for cancer therapy or as an
alternative for the production of non-fucosylated antibodies with
enhanced ADCC.
Table 1 Data collection and refinement statistics.
HsFUT8 in complex with GDP and G0
Data collection
Space group C2
Cell dimensions
a, b, c (Å) 208.04, 68.59, 173.92
α, β, γ (°) 90, 149.90, 90
Resolution (Å) 20–1.95 (2.06–1.95)a
Rmerge 0.133 (1.368)
I/σI 6.4 (1.4)
Completeness (%) 99.9 (100)
Redundancy 4.4 (4.5)
Refinement
Resolution (Å) 1.95
No. of reflections 394,687
Rwork/Rfree 0.185/0.218
No. of atoms
Protein 7511
GDP 56
G0 180
Waters 506
Glycerol 102
B-factors (Å2)
Protein 38.11
GDP 47.64
G0 44.70
Waters 49.00
Glycerol 63.01
R.m.s. deviations
Bond lengths (Å) 0.0159
Bond angles (°) 2.0646
One crystal was used to determine the crystal structure. aValues in parentheses are for highest-
resolution shell.
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Fig. 4 Overall structure of HsFUT8 complexed to GDP and G0. a Ribbon structure of HsFUT8 with GDP (orange carbon atoms) and G0 (green carbon
atoms). The coiled-coil, catalytic and SH3 domains are colored in gray, red and orange, respectively. The interdomain α3 and loop β10–β11 are colored in
blue and aquamarine, respectively. Disulfide bridges are indicated as yellow sulfur atoms. The C-terminal loop is colored in black. (inset) Electron density
maps are FO–FC (blue) contoured at 2.2σ for GDP and G0. The labels of the sugar units (A–G) are also shown. b Surface representation of the HsFUT8-
GDP-G0 complex. c Superposition of HsFUT8 apo (pink) and substrate-bound (gray) forms. This figure also depicts the conformational changes visualized
in residues 365–378 and 428–444. These regions are represented as aquamarine (apo form) and blue (substrate-bound form).
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Fig. 3 Dimeric structure of HsFUT8. One HsFUT8 molecule (A in gray) from one asymmetric unit forms a dimeric structure with another molecule (B* in
blue) from the other asymmetric unit* through their corresponding coiled-coil domains.
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Fig. 5 Structural features of GDP-Fuc and G0 binding sites. a Complete GDP-Fuc and G0 binding sites of the HsFUT8-GDP-G0 complex. The residues
forming the GDP-Fuc/AG0/BG0 and CG0/DG0/EG0/FG0/GG0 binding sites are depicted as gray and aquamarine/orange carbon atoms, respectively. GDP,
G0 and glycerol are shown as orange, green and blue carbon atoms, respectively. Hydrogen bond interactions are shown as dotted black lines. b, c Close-
up view of the binding site region of the HsFUT8-GDP-G0 and HsFUT8-GDP-Fuc-G0 complexes showing the essential residues (Arg365, Lys369 and
Glu373) that are major players in the plausible SN2 single-displacement reaction mechanism. Note the proximity and the orientation of the AG0 OH6 to the
anomeric carbon (4.48 Å) which is compatible with the inversion of the configuration during the reaction.
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Fig. 6 The bisecting GlcNAc in N-glycans. N-glycans carrying a bisecting
GlcNAc are not substrates of HsFUT8 likely due to a steric clash between
the bisecting GlcNAc with Ala532 (distance of 4.46 Å between the Ala532
backbone and CG0 OH4). Note that the bisecting GlcNAc would be bound
to CG0 via the CG0 OH4, and it is this GlcNAc who would have a steric
clash with Ala352. It is also likely that the addition of the bisecting GlcNAc
causes conformational changes to the neighboring branching sugar
moieties, which could contribute to disrupt the binding to HsFUT8.
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Fig. 7 Superposition of HsFUT8 apo (pink) and substrate-bound (gray)
forms. This figure also depicts the conformational changes visualized in
Glu373 (in aquamarine and blue for the apo and substrate-bound form,
respectively).
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Methods
Glycan preparation. For the preparation of the biantennary complex A2 N-glycan
(named here as G0), sialyl glycopeptide (SGP) predominantly glycosylated with
A2G2S2 glycan was isolated from hen's egg yolk according to a published proce-
dure31 and further enzymatically and chemically processed. Treatment of the
glycopeptide with acetic acid at 80 °C removed sialic acid residues32 and degly-
cosylation with PNGase F (Asparia Glycomics) produced a mix of mono and bis-
galactosylated glycans33. The obtained mixture (110 mg, 66.8 µmol) was dissolved
in 50 mM citric phosphate buffer (8 mL, pH= 5). Aspergillus niger β-galactosidase
(8.9 U/mg, 14.2 mg, in 1260 µL buffer) and an aqueous solution of 0.02% NaN3
were added. The reaction mixture was incubated at 37 °C and the reaction progress
monitored via MALDI-TOF MS. After complete degalactosylation, MeOH (5 mL)
was added and the reaction mixture centrifuged at 4500 r.p.m. MeOH was removed
under reduced pressure and the supernatant was loaded onto a Bond elute graphite
cartridge (10 g) and eluted with H2O (250 mL), 25% MeOH/H2O (500 mL), 50%
MeOH/H2O (250 mL). The collected fractions of 50% MeOH were analyzed by
MALDI-TOF MS and fractions containing pure product were pooled and lyo-
philized. The pure product G0 was obtained as a white solid (69.1 mg, 52.5 µmol,
79%). 1H NMR (500MHz, D2O, 298 K): δ 5.10 (s, 1H, αH-1GlcNAc-1), 5.02 (s, 1H,
H-1αMan-2), 4.83 (s, 1H, H-1αMan-3), 4.68 (s, 1H, H-1βMan-1), 4.62–4.59 (m, 1H, βH-
1GlcNAc-1), 4.54–4.50 (m, 1H, H-1βGlcNAc-2), 4.46 (d, J= 8.4 Hz, 2H, H-1βGlcNAc-3,
H-1βGlcNAc-4), 4.16 (s, 1H, H-2αMan-2), 4.10 (s, 1H, H-2αMan-3), 4.02 (s, 1H, H-
2αMan-1), 3.90–3.31 (m, 39H), 1.99 (s, 3H, CH3,GlcNAc), 1.96 (s, 6H, CH3,GlcNAc),
1.95 (s, 3H, CH3,GlcNAc). 13C NMR (126MHz, D2O, 298 K): δ 174.8, 174.7, 174.6
(4× CO), 101.3 (C1βGlcNAc-2), 100.4 (C1βMan-1), 99.5 (C1βMan-2, C1βGlcNAc2,
C1βGlcNAc3), 97.0 (C1βMan-3), 94.8 (βC1GlcNAc-1), 90.6 (αC1αGlcNAc-1), 79.6, 79.5,
79.2, 76.4 (C2Man-3), 76.3 (C2Man-1), 75.8, 74.3, 73.5, 73.4, 73.2, 72.8, 72.4, 72.0, 69.9
(C2Man-2), 69.2, 67.3, 65.7, 61.6, 60.6, 59.9, 55.3 (C2GlcNAc-4), 54.9 (C2GlcNAc-3), 53.6
(C2GlcNAc-1, C2GlcNAc-2), 22.3, 22.2, 21.8 (4× CH3). HRMS (MALDI-TOF): calcd
for C50H84N4O36Na [M+Na]+ 1339.475, found 1339.515.
Activity assay on 5-aminopentyl G0. G0 containing a C5 linker at the anomeric
position of the reducing end (5-aminopentyl G034) (1 nmol), guanosine 5′-
diphospho-β-L-fucose (GDP-Fuc) (2 nmol) and HsFUT8 (18 µM) in Tris 25 mM,
150 mM NaCl pH= 7.5 were incubated at room temperature (rt) for 5 h. MALDI-
TOF MS analysis of the reaction mixture employing a solution of 2,5-dihydrox-
ybenzoic acid (DHB, 5 mg/mL in acetonitrile) as matrix showed the formation of
fucosylated 5-aminopentyl G0. Control experiments lacking HsFUT8 and GDP-
Fuc were performed showing the unaltered 5-aminopentyl G0 by MALDI-TOF MS
(Supplementary Fig. 1).
Glycan array analysis. HsFUT8 screening on glycan microarrays was performed
as previously described with slight modifications13. Each subarray was incubated
with a solution (200 µL) containing two different concentrations of FUT8 (650 nM
and 3.25 µM), GDP-Fuc (0.5 mM), MnCl2 (10 mM) in Tris 25 mM, 150 mM NaCl
pH= 7.5 at rt overnight. The supernatant was removed and the slide was washed
with PBS and water. The introduction of Fuc residues by the action of FUT8 was
probed by incubation with Aleuria aurantia lectin (Vector laboratories, Burlin-
game, CA, USA) labeled with Alexa Fluor™ 555 NHS succinimidyl ester (Thermo
Fisher, AAL-555, 60 µg/mL in binding buffer: Tris 25 mM, 150 mM NaCl pH= 7.5
containing 0.01% Tween-20) at rt for 1 h. The microarray slide was washed with
binding buffer, and water and fluorescence was analyzed on an Agilent G265BA
microarray scanner system (Agilent Technologies, Santa Clara, USA). Quantifi-
cation was performed with ProScanArray® Express (Perkin Elmer, Shelton, USA)
and Microsoft Excel software. The average of mean RFU values after background
subtraction and standard deviation for four replicate spots was represented as
histograms employing GraphPad Prism 6 software.
Expression and purification of HsFut8. The DNA sequence encoding amino acid
residues 68–575 of the HsFUT8 was codon optimized and synthesized by Gen-
Script (USA) for expression in HEK293 cells (see Supplementary Table 2 for the
codon optimized sequence). The DNA, containing at the 5′-end a recognition
sequence for KpnI, and at the 3′ end a stop codon and a recognition sequence for
XhoI, was cloned into a modified pHLSec containing after the secretion signal
sequence a 12xHis tag, a superfolder GFP35 and a Tobacco Etch Virus (TEV)
cleavage site, rendering the vector pHLSec-12His-GFP-TEV-HsFUT8. Both the
synthesis of the HsFUT8 construct and the engineered pHLSec together with the
cloning of HsFUT8 into pHLSec-12His-GFP-TEV were performed by GenScript.
pHLSec-12His-GFP-TEV-HsFUT8 was transfected into HEK293F cell line
(Thermo Fisher Scientific) as described below. Cells were grown in suspension in a
humidified 37 °C and 8% CO2 incubator with rotation at 125 r.p.m. Transfection
was performed at a cell density of 2.5 × 106 cell/mL in fresh media F17 serum-free
media with 2% Glutamax and 0.1% P188. For each 150 mL of culture, 450 μg of the
plasmid (1 μg/μL) was diluted to 135 µL with sterilized 1.5 M NaCl. This mixture
was added to each 150 mL cell culture flask and incubated for 5 min in the
incubator. After that, 1.35 mg of PEI-MAX (1 mg/mL) was mixed to 135 µL with
sterilized 1.5 M NaCl and added to the cell culture flask. Cells were diluted 1:1 with
pre-warmed media supplemented with valproic acid 24 h post-transfection to a
final concentration of 2.2 mM. Cells were harvested 6 days post-transfection by
spinning down at 300 × g for 5 min, after which the supernatants were collected
and centrifuged at 4,000 × g for 15 min.
Supernatant was dialyzed against buffer A (25mM TRIS pH 7.5, 300mM NaCl)
and loaded into a His-Trap Column (GE Healthcare). Protein was eluted with an
imidazol gradient in buffer A from 10mM up to 500mM. Buffer exchange to 25
mM TRIS pH 7.5, 150mM NaCl (buffer B) was carried out using a HiPrep 26/10
Desalting Column (GE Healthcare). TEV protease was then added in a ratio 1:50
(TEV:protein) to the fusion construct in order to cleavage the His-GFP. After 20 h
of reaction at 18 °C, the cleavage was satisfactorily verified through SDS-PAGE.
TEV protease and GFP were later removed from the solution using a His-Trap
Column (GE Healthcare), and isolated HsFUT8 was then loaded into a HiLoad 26/
60 Superdex 75 Colum (GE Healthcare), previously equilibrated with buffer B.
Quantification of protein was carried out by absorbance at 280 nm using his
theoretical extinction coefficient (ε280 nmHsFut8= 90,760M−1 cm−1).
Crystallization and data collection. Crystals of the HsFUT8 were grown by sitting
drop experiments at 18 °C by mixing 0.5 μL of protein solution (4.5 mg/mL
HsFUT8, 5 mM GDP and 5mM G0 in buffer B) with an equal volume of a
reservoir solution (0.1 M carboxilic acids, 0.1 M buffer system 3 pH 8.5 and 30%
precipitant mix 1 (Molecular Dimensions). The crystals were cryoprotected in
mother liquor containing 30% glycerol and flash frozen in liquid nitrogen.
Structure determination and refinement. Diffraction data were collected on
the synchrotron beamline I24 of the Diamond Light Source (Harwell Science and
Innovation Campus, Oxfordshire, UK) at a wavelength of 0.97 Å and a temperature
of 100 K. Data were processed and scaled using XDS36 and CCP4 (refs. 37,38) soft-
ware packages. Relevant statistics are given in Table 1. The crystal structure was
solved by molecular replacement with Phaser37,38 using the PDB entry 2DE0 as the
template. Initial phases were further improved by cycles of manual model building in
Coot39 and refinement with REFMAC5 (ref. 40). Further rounds of Coot and
refinement with REFMAC5 were performed to obtain the final structure. The
final model was validated with PROCHECK; model statistics are given in Table 1.
The AU of the C2 crystal contained two molecules of HsFUT8. The Ramachandran
plots for the HsFUT8-GDP-G0 show that 92.1%, 7.6%, 0.2% and 0% of the amino
acids are in most favored, allowed, generously allowed and disallowed regions,
respectively.
Molecular mechanics minimizations. GDP-Fuc was obtained from CePoFUT1 in
complex with GDP-Fuc (PDB entry: 3ZY6 (ref. 25)) and then it was superimposed
on our crystal structure. The calculations were carried out on the complexes using
AMBER 18 package, which was implemented with ff14SB, GLYCAM06 and GAFF
force fields. The complex was immersed in a water box with a 10 Å buffer of TIP3P
water molecules and neutralized by adding explicit Na+. A two-stage geometry
optimization approach was performed with a total of 5000 minimization steps and
using the default settings of AMBER 18. The first stage minimizes only the posi-
tions of solvent molecules and ions, and the second stage is an unrestrained
minimization of all the atoms in the system.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The crystal structure of the HsFUT8-GDP-G0 complex was deposited at the RCSB PDB
with accession code 6TKV. The source data underlying Fig. 2 are provided as a Source
Data file. Other data are available from the corresponding author upon reasonable
request.
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